The Environmental Illness Resource Blog

Commentary on environmental toxins and chronic illness.

Fecal microbial transplantation found to be possible treatment

Posted by: Bushi

Tagged in: Untagged 

Bushi

 

The phase I clinical trial of the procedure was conducted by members of the Pediatric Specialty Department of the Spectrum Health Medical Group at Helen DeVos Children's Hospital, the first in the country to study FMT in children. FMT is a process that involves infusion of human stool from a healthy donor into the intestine of the patient in an attempt to restore healthy microbial flora in the intestines of the patient. When used to treat a disease, human stool constitutes a drug and a biologic. Therefore, an investigational new drug approval was obtained from the United States Food and Drug Administration (FDA) to utilize FMT for treating ulcerative colitis in this trial.


Poor Results Achieved With Fecal Transplantation for Ulcerative Colitis

Posted by: Bushi

Tagged in: Untagged 

Bushi

 

Only one of five patients with moderate to severe ulcerative colitis (UC) who were treated with fecal transplantation (FT) experienced clinical and endoscopic improvements following the procedure, according to an abstract presented at the 2012 United European Gastroenterology Week (abstract P374).


 

  • Everyone's skin carries acne-causing bacteria, of which there are 'good' and 'bad' strains
  • Having too much 'bad' bacteria is what causes acne
  • Findings could pave the way for new treatments






NimotopI first read about the drug nimodipine (Nimotop) being used in very small dosages to treat chronic fatigue syndrome (ME/CFS) and related 'environmental', or 'invisible' illnesses (e.g. fibromyalgia, multiple chemical sensitivity) over a decade ago. Looking back I am not sure what prompted me to cast it aside so easily as a treatment option but this is what I did. I think perhaps I was more focused on resolving my gut dysbiosis issues which I saw (and still see) as the main driver of my ill-health. I also was more averse to opting for pharmaceutical interventions than I am now. Regardless, after reading of the recoveries of Dr. Mason-Brown MD and psychologist Dr. Kristina Downing-Orr in the latter's book Beating Chronic Fatigue using nimodopine as the basis, I have decided it is time to give it a shot.

In the intervening period since reading about nimodipine use in ME/CFS I have managed to overcome multiple chemical sensitivities (MCS) and learnt methods to manage what was crippling and life-threatening seasonal affective disorder (SAD). Unfortunately I have found myself going around in many  circles and hitting many brick walls when it comes to tackling the ME/CFS from which I have suffered for 20+ years. All reasonable options are therefore on the table.


Bacteriotherapy Achieves 70% Success Rate in CFS Patients

Posted by: Bushi

Tagged in: Untagged 

Bushi

Editor’s Comment: This study builds on previous research demonstrating abnormal bacterial gut flora in ME/CFS patients. In addition to causing numerous gastrointestinal symptoms, prior studies have found that abnormal gut flora in ME/CFS patients is linked to cognitive dysfunction (Maes and De Meirleir). This is the first study to demonstrate a complete remission of symptoms in a significant percentage of ME/CFS patients after the normalization of gut flora.


Good Bacteria May Expunge Vancomycin-Resistant Bacteria from Your Gut

Posted by: Bushi

Tagged in: Untagged 

Bushi

 

Too much antibiotic can decimate the normal intestinal microbiota, which may never recover its former diversity. That, in turn, renders the GI tract vulnerable to being colonized by pathogens. Now researchers from Memorial Sloan-Kettering Cancer Center, New York, NY, and Centro Superior de Investigación en Salud Pública, Valencia, Spain, show that reintroducing normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) from the intestinal tracts of mice. The investigators showed further that the findings may apply to humans.


Could An Antibiotic From Human Sweat Fight Hospital Superbugs And TB?

Posted by: Bushi

Tagged in: Untagged 

Bushi

An antibiotic created from human sweat might fight off hospital superbugs and deadly strains of tuberculosis, scientists reported in Proceedings of the National Academy of Sciences.



The researchers, from Scotland, Germany, France and Spain explained that a protein found on human skin - Dermcidin - is activated in sweat (slightly acidic and salty environments) and kills harmful microbes by perforating their cell membranes.


 

Scientists have long puzzled over why "bad" bacteria such as E. coli can thrive in the guts of those with inflammatory bowel disease (IBD), causing serious diarrhea. Now UC Davis researchers have discovered the answer—one that may be the first step toward finding new and better treatments for IBD.


X-ray device traps airborne pathogens and neutralizes them

Posted by: Bushi

Tagged in: Untagged 

Bushi

 

Help may be on the way for people with compromised immune systems, severe allergies, or who otherwise have to be wary of airborne nasties. A team of scientists have created something known as a soft x-ray electrostatic precipitator, or an SXC ESP for short. It filters all manner of bacteria, allergens, viruses, and ultrafine particles from the air – plus, it kills everything it catches.


SCIENTISTS HOME IN ON KILLER BUG

Posted by: Bushi

Tagged in: Untagged 

Bushi

 

UK scientists have discovered a secret ‘Sat Nav’ that enables them to identify and zap a potential killer bug in the body’s system.


<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

 

 

Active Groups

EiR on Facebook

Follow us on Facebook

EiR on Google+



EiR on Twitter


Follow The EiR on Twitter

Online Members

0 users online